Skip to content

The Impact of Grand Tour Cycling on Sleep and the Hematological and Metabolomic Profile in World-class Cyclists

The Impact of Grand Tour Cyling on Sleep and the Hematological and Metabolomic Profile in World-class Cyclists

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06386900
Enrollment
16
Registered
2024-04-26
Start date
2023-07-01
Completion date
2024-12-01
Last updated
2024-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overreaching

Keywords

Cycling, Grand Tour, Sleep, Metabolomics

Brief summary

This project aims to identify the effect of a 3-week Grand Tour (e.g. Tour de France, Giro d'Italia, and Vuelta a España) on sleep, hematological parameters and the serum metabolome in world-class cyclists.

Interventions

OTHERCyclist

Participating in the Grand Tour as cyclist

Sponsors

KU Leuven
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years

Inclusion criteria

* Cylist participating in a Grand Tour (e.g. Tour de France, Vuelta a España, Giro d'Italia)

Exclusion criteria

* /

Design outcomes

Primary

MeasureTime frameDescription
Sleep efficiency during the Grand TourEvery night starting from one week before till the last night of the Grand TourPercentage change in sleep efficiency during the Grand Tour (measured by OURA ring)
Total sleep time during the Grand TourEvery night starting from one week before till the last night of the Grand TourChange in total sleep time during the Grand Tour (measured by OURA ring)
Serum metabolome abundance of cyclists participating in a Grand TourStart of the Grand Tour - restday 1 of the Grand Tour - restday 2 of the Grand Tour - last day of the Grand TourChanges in the abundance of serum metabolites within the cyclists between 4 timepoints (measured by mass spectrometry)
Blood haemoglobin concentrationStart of the Grand Tour - restday 1 of the Grand Tour - restday 2 of the Grand Tour - last day of the Grand TourChange in the blood haemoglobin concentration during the Grand Tour

Secondary

MeasureTime frameDescription
Red blood cell concentrationStart of the Grand Tour - restday 1 of the Grand Tour - restday 2 of the Grand Tour - last day of the Grand TourChange in red blood cell concentration during the Grand Tour
Wakefulness after sleep onsetEvery night starting from one week before till the last night of the Grand TourPercentage change in wakefulness after sleep onset during the Grand Tour (measured by OURA ring)
Subjective fatigueStart of the Grand Tour - restday 1 of the Grand Tour - restday 2 of the Grand Tour - last day of the Grand TourAbsolute change in subjective fatigue during the Grand Tour (measured by 11-point scale)
Light sleepBefore the start of the Tour - restday 1 - restday 2 - end of Grand TourPercentage change in light sleep during the Grand Tour (measured by OURA ring)
Deep sleepBefore the start of the Tour - restday 1 - restday 2 - end of Grand TourPercentage change in deep sleep during the Grand Tour (measured by OURA ring)
REM sleepBefore the start of the Tour - restday 1 - restday 2 - end of Grand TourPercentage change in REM sleep during the Grand Tour (measured by OURA ring)

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026